Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension
Authors:
- 3 February 2010
- journal article
- research article
- Published by Taylor & Francis in Experimental Lung Research
- Vol. 36 (1) , 57-66
Abstract
Monocrotaline (MCT)-induces progressive disruption of endothelial cell membrane and caveolin-1 leading to pulmonary arterial hypertension (PAH). Treatment instituted early rescues caveolin-1 and attenuates PAH. To test the hypothesis that the poor response to therapy in established PAH is due to progressive deregulation of multiple signaling pathways, the authors investigated time-dependent changes in the expression of caveolin-1, gp130, PY-STAT3, Bcl-xL, and the molecules involved in NO signaling pathway (endothelial nitric oxide synthase [[eNOS]], heat sock protein 90 [[HSP90]], Akt, soluble guanylate cyclase [[sGC]] α1 and β1 subunits). PAH and right ventricular hypertrophy (RVH) were observed at 2 and 3 weeks. Progressive loss of endothelial caveolin-1 and sGC (α1, β1), PY-STAT3 activation, and Bcl-xL expression were observed at 1 to 3 weeks post-MCT. The expression of gp130 increased at 48 hours and 1 week, with a subsequent loss at 2 and 3 weeks. The expression of eNOS increased at 48 hours and 1 week post-MCT, with a significant loss at 3 weeks. The expression of HSP90 and Akt decreased at 2 and 3 weeks post-MCT concomitant with PAH. Thus, MCT induces progressive loss of membrane and cytosolic proteins, resulting in the activation of proliferative and antiapoptotic factors, and deregulation of NO signaling leading to PAH. An attractive therapeutic approach to treat PAH may be an attempt to rescue endothelial cell membrane integrity.Keywords
This publication has 45 references indexed in Scilit:
- Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclaseFEBS Letters, 2007
- Pulmonary Artery HypertensionCardiology in Review, 2007
- SOCS proteins and caveolin-1 as negative regulators of endocrine signalingTrends in Endocrinology & Metabolism, 2006
- Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivinJournal of Cell Science, 2006
- Disruption of Endothelial-Cell Caveolin-1α/Raft Scaffolding During Development of Monocrotaline-Induced Pulmonary HypertensionCirculation, 2004
- Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expressionCardiovascular Research, 2004
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma CellsJournal of Biological Chemistry, 2003
- Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in ratsCardiovascular Research, 1995